Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study to Determine the Safety and Efficacy of AMG 827 in Subjects With Inadequately Controlled Asthma

NCT01199289 is registered in ClinicalTrials.gov with Amgen as lead sponsor.

NCT NCT01199289
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01199289 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study to Determine the Safety and Efficacy of AMG 827 in Subjects With Inadequately Controlled Asthma
Lead sponsor
Amgen
Phase
Phase 2
Overall status
Completed
Start date
October 4, 2010
Completion date
December 21, 2011
Enrollment
315 (actual)
Sites
49

Conditions

As the registry lists them; a condition with its own page is linked.

asthma